circ_0001274 Competitively Binds miR-143-3p to Upregulate VWF Expression to Improve Acute Traumatic Coagulopathy

Area of Science:

• Molecular Biology
• Genetics
• Hematology

Background:

• Competing endogenous RNA (ceRNA) networks involving circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) are implicated in disease pathogenesis.
• Acute traumatic coagulopathy (ATC) is a complex bleeding disorder requiring novel therapeutic targets.

Purpose of the Study:

• To investigate the circRNA-miRNA-mRNA ceRNA regulatory network in the context of ATC.
• To identify key molecular players and their interactions in ATC development and progression.

Main Methods:

• Bioinformatic analysis of online databases and high-throughput circRNA sequencing to identify potential ceRNA networks.
• Experimental validation of the circ_0001274/miR-143-3p/VWF axis in ATC patient samples and mouse models.
• Assays to determine gene expression levels and functional interactions between circ_0001274, miR-143-3p, and VWF.

Main Results:

• Vascular Endothelial Growth Factor (VWF) was identified as a key gene in ATC, exhibiting low expression in patients and mouse models.
• miR-143-3p was found to directly target and inhibit VWF expression.
• circ_0001274 was demonstrated to act as a molecular sponge for miR-143-3p, thereby upregulating VWF expression.

Conclusions:

• The circ_0001274/miR-143-3p/VWF axis plays a critical role in regulating VWF expression in ATC.
• Upregulation of circ_0001274 presents a potential therapeutic strategy for improving outcomes in ATC by restoring VWF levels.